Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
PumaBiotech (@pumabiotech) / Twitter
Puma Biotechnology
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
Puma Biotechnology
PumaBiotech (@pumabiotech) / Twitter
SEC charges former Puma biotech exec with $1.1 million in insider trading
Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool
Puma Biotechnology
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotech shares slide after glimpse of trial data on cancer drug | Financial Times
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Is Puma Biotechnology a Buy? | The Motley Fool
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
Puma Biotechnology
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Jobs with Puma Biotechnology
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology
Takeda farms out cancer drug alisertib to Puma Biotech -
